Literature DB >> 8138807

Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies.

N Shiraiwa1, A Ishii, H Iwamoto, H Mizusawa, Y Kagawa, S Ohta.   

Abstract

A point mutation of mitochondrial tRNALeu(UUR) gene is responsible for a MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) subgroup of mitochondrial encephalomyopathies. In most cases, the mutant mitochondrial DNA (mtDNA) coexists with normal mtDNA in a heteroplasmic manner. In order to quantify the content of mutant mtDNA, we developed a quantitative method of PCR. Using this method, the distribution of the mutant mtDNA was examined in 32 different tissues among 18 autopsied organs from a patient with MELAS, who had shown hypophyseal dysfunction. The percentage of the mutant mtDNA at nucleotide number 3243 in each tissue was ranged between 22% and 95%. The content of the mutant mtDNA was at the highest (95%) in the hypophysis and higher in the cerebral cortex than in the white matter. This study shows a possible correlation of tissue dysfunction with accumulation of the mutant mtDNA within the brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8138807     DOI: 10.1016/0022-510x(93)90270-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

2.  Rapid and sensitive real-time polymerase chain reaction method for detection and quantification of 3243A>G mitochondrial point mutation.

Authors:  Rinki Singh; Sian Ellard; Andrew Hattersley; Lorna W Harries
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

Review 3.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

4.  Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS.

Authors:  Mahsa Mehrazin; Sara Shanske; Petra Kaufmann; Ying Wei; Jorida Coku; Kristin Engelstad; Ali Naini; Darryl C De Vivo; Salvatore DiMauro
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

Review 5.  Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain.

Authors:  Jose M Garcia-Heredia; Amancio Carnero
Journal:  Oncotarget       Date:  2015-12-08

6.  Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease.

Authors:  Rachel L Boal; Yi Shiau Ng; Sarah J Pickett; Andrew M Schaefer; Catherine Feeney; Alexandra Bright; Robert W Taylor; Doug M Turnbull; Grainne S Gorman; Tim Cheetham; Robert McFarland
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

7.  Adult-onset of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome with hypothyroidism and psychiatric disorders.

Authors:  Yu-Xing Ge; Bo Shang; Wen-Zhen Chen; You Lu; Jue Wang
Journal:  eNeurologicalSci       Date:  2016-11-04

8.  Heteroplasmy and Copy Number in the Common m.3243A>G Mutation-A Post-Mortem Genotype-Phenotype Analysis.

Authors:  Leila Motlagh Scholle; Stephan Zierz; Christian Mawrin; Claudia Wickenhauser; Diana Lehmann Urban
Journal:  Genes (Basel)       Date:  2020-02-18       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.